CVS Health (CVS) Tops Q4 EPS by 1c, Reaffirms Outlook

CVS Health (NYSE: CVS) reported Q4 EPS of $1.21, $0.01 better than the analyst estimate of $1.20. Revenue for the quarter came in at $37.1 billion versus the consensus estimate of $36.06 billion. Comps increased 1.6%.

2015 Guidance:

• Confirmed full year Adjusted EPS of $5.05 to $5.19; GAAP diluted EPS from continuing operations of $4.77 to $4.91
• Confirmed first quarter Adjusted EPS of $1.06 to $1.09; GAAP diluted EPS from continuing operations of $0.99 to $1.02
• Confirmed full year free cash flow of $5.9 to $6.2 billion; confirmed cash flow from operations of $7.6 to $7.9 billion

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Aspire Biopharma to acquire automotive supplier for $30 million
• BIG3 Basketball to go public via Graf Global merger at $290 million